What should be monitored regularly when prescribing sodium valproate?

When prescribing sodium valproate, it is essential to regularly monitor liver function tests due to the medication's potential hepatotoxicity. Sodium valproate can cause liver damage, especially in the first six months of treatment or when dosage adjustments are made, making it critical to assess liver enzymes periodically. Regular monitoring helps detect any signs of liver dysfunction early, allowing for timely intervention if needed.

While other factors such as heart rate, thyroid levels, and blood pressure may be relevant for overall patient management, they are not specifically associated with the safety and efficacy monitoring of sodium valproate therapy. Thus, the focus on liver function tests is vital for ensuring patient safety while on this medication.